查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1533902

新生儿听力筛检设备的全球市场

Neonatal Hearing Screening Devices
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 274 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球新生儿听力筛检设备市场预计将达到 4,940 万美元

新生儿听力筛检设备的全球市场预计 2023 年为 3,960 万美元，预计到 2030 年将达到 4,940 万美元，2023-2030 年分析期间复合年增长率为 3.2%。听觉脑干反应 (ABR) 系统是本报告分析的细分市场之一，预计复合年增长率为 3.3%，到分析期结束时将达到 2,250 万美元。分析期间，耳声发射 (OAE) 系统产业的复合年增长率预计为 3.8%。

美国市场预估成长1,080万美元，中国复合年增长率为6.2%

预计 2023 年美国新生儿听力筛检设备市场规模将达到 1,080 万美元。中国作为世界第二大经济体，预计2030年市场规模将达到1,010万美元，2023年至2030年分析期间复合年增长率为6.2%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 1.0% 和 2.4%。在欧洲，德国的复合年增长率预计为 1.7%。

全球新生儿听力筛检设备市场 - 主要趋势与驱动因素总结

新生儿听力筛检被公认为是识别听力损失的重要早期疗育工具，对儿童的语言和社会性发展有重大影响。新生儿听力筛检(UNHS) 越来越多地在世界各地的医院中实施，因为早期检测可以显着减少听力损失的影响。新生儿听力筛检是在出生后不久进行的，使用一系列非侵入性、无痛的测试来快速确定宝宝的听力健康状况。婴儿的语言发展技能在生命的第一年迅速提高，因此早期发现和介入对于防止未来的沟通和教育挑战至关重要。

科技的进步大大提高了新生儿听力筛检的有效性和可近性。现代设备整合了声发射 (OAE) 和听觉脑干反应 (ABR) 测试，并且改进的刺激（例如 CE-Chirp）现在可以实现更快、更准确的全面听力评估。这种整合简化了筛检过程，减少了对多种仪器的需求，并减少了整体测试时间。此外，这些设备的进步使它们更易于使用并允许连接到资料库，从而可以系统地管理和分析患者记录，从而促进后续护理和听力健康的纵向研究变得更加容易。

新生儿听力筛检市场的成长受到多种因素的推动，包括技术进步，例如设备与远端医疗服务的集成，扩大了服务不足地区的覆盖范围。此外，感测器技术的增强正在提高筛检的准确性和可靠性，从而增加其采用率。该设备可携式易于使用的设计不仅便于在医院使用，而且还可以在社区中心和家庭中使用，从而扩大了早期检测的范围。此外，在教育宣传活动和监管支持的支持下，消费者意识的提高正在推动更广泛的日常使用。设备製造商和医疗保健专业人员之间的合作不断改进设备，提高其在临床环境中的适应性和有效性。对医院采用这些筛检通讯协定的经济奖励确保了更广泛的采用，并有助于这项基本医疗保健技术的整体成长和进步。

受访企业范例（共37家）

  • Draeger India Private Limited
  • Echodia SAS
  • Grason-Stadler, Inc.
  • Guangzhou Melison Medical Instrument Co., Ltd.
  • iClear Healthcare
  • Intelligent Hearing Systems Corp.
  • Interacoustics A/S
  • MAICO Diagnostics GmbH
  • Natus Medical Incorporated
  • Neurosoft
  • Otodynamics Ltd
  • Path Medical GmbH
  • Pilot Blankenfelde medizinisch elektronische Gerate GmbH
  • Sohum Innovation Lab
  • Vivosonic Inc.;

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP24719

Global Neonatal Hearing Screening Devices Market to Reach US$49.4 Million by 2030

The global market for Neonatal Hearing Screening Devices estimated at US$39.6 Million in the year 2023, is expected to reach US$49.4 Million by 2030, growing at a CAGR of 3.2% over the analysis period 2023-2030. Auditory Brainstem Response (ABR) Systems, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$22.5 Million by the end of the analysis period. Growth in the Otoacoustic Emission (OAE) Systems segment is estimated at 3.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$10.8 Million While China is Forecast to Grow at 6.2% CAGR

The Neonatal Hearing Screening Devices market in the U.S. is estimated at US$10.8 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$10.1 Million by the year 2030 trailing a CAGR of 6.2% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.0% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.7% CAGR.

Global Neonatal Hearing Screening Devices Market - Key Trends and Drivers Summarized

Neonatal hearing screening is recognized as a crucial early intervention measure to identify hearing loss, which can profoundly impact a child's development of speech, language, and social skills. Hospitals around the world are increasingly incorporating Universal Newborn Hearing Screening (UNHS) programs, motivated by the potential to significantly mitigate the effects of auditory impairments recognized early in life. The process, conducted shortly after birth, involves a series of non-invasive, painless tests that can quickly determine a baby's auditory health status. This proactive approach is crucial because a baby’s capacity for speech and language development accelerates within the first year of life, making early detection and intervention essential for preventing future communicative and educational challenges.

Technology advancements have greatly enhanced the efficacy and accessibility of newborn hearing screenings. Modern devices integrate both Otoacoustic Emissions (OAE) and Auditory Brainstem Response (ABR) tests, allowing for comprehensive auditory assessments that are both faster and more accurate, thanks to improved stimuli like CE-Chirp. This integration simplifies the screening process, reduces the need for multiple devices, and accelerates the overall testing time—factors that increase efficiency in a clinical setting. Moreover, the evolution of these devices has made them more user-friendly and capable of connecting to databases, which helps in maintaining and analyzing patient records systematically, facilitating follow-up care and longitudinal studies on auditory health.

The growth in the neonatal hearing screening market is driven by several factors including technological advancements, such as the integration of devices with telehealth services, which expand reach to underserved areas. Additionally, enhancements in sensor technology improve the accuracy and reliability of screenings, increasing their adoption. Portable and user-friendly designs of the devices promote their use not only in hospitals but also in community centers and at home, broadening the scope of early detection. Furthermore, increased consumer awareness, backed by educational campaigns and regulatory support, encourages more widespread and routine use. Collaboration between device manufacturers and healthcare professionals continues to refine the devices, making them more adaptable and effective in clinical environments. Economic incentives for hospitals to adopt these screening protocols ensure a broader implementation, contributing to the overall growth and development of this essential healthcare technology.

Select Competitors (Total 37 Featured) -

  • Draeger India Private Limited
  • Echodia S.A.S
  • Grason-Stadler, Inc.
  • Guangzhou Melison Medical Instrument Co., Ltd.
  • iClear Healthcare
  • Intelligent Hearing Systems Corp.
  • Interacoustics A/S
  • MAICO Diagnostics GmbH
  • Natus Medical Incorporated
  • Neurosoft
  • Otodynamics Ltd
  • Path Medical GmbH
  • Pilot Blankenfelde medizinisch elektronische Gerate GmbH
  • Sohum Innovation Lab
  • Vivosonic Inc.;

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Neonatal Hearing Screening Devices - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Need to Identify Congenital Deafness & Hearing Impairment in Newborns Drives Demand
    • Technological Advancements in Screening Devices Enhance Detection Accuracy
    • Smartphone-Based Hearing Test for Infants Ignites Interest in the Market
    • Growing Healthcare Expenditure in Emerging Markets Bolsters Device Adoption
    • Development of Low-cost Earbuds Makes Newborn Hearing Screening Accessible
    • Telemedicine for Audiology Screening of Infants Rises in Popularity
    • Economic Burden of Undiagnosed Hearing Loss Supports Case for Early Screening
    • Adoption of Newborn Hearing Screening in Private Healthcare Sectors
    • Growing Number of Births in Medical Facilities Increases Market Coverage
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Neonatal Hearing Screening Devices Market Analysis of Annual Sales in US$ for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Neonatal Hearing Screening Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 4: World 16-Year Perspective for Neonatal Hearing Screening Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Auditory Brainstem Response (ABR) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Auditory Brainstem Response (ABR) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 7: World 16-Year Perspective for Auditory Brainstem Response (ABR) Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Otoacoustic Emission (OAE) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Otoacoustic Emission (OAE) Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 10: World 16-Year Perspective for Otoacoustic Emission (OAE) Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Combination Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Combination Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 13: World 16-Year Perspective for Combination Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 16: World 16-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Specialty Clinics End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 19: World 16-Year Perspective for Specialty Clinics End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 22: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • JAPAN
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • CHINA
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • EUROPE
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Neonatal Hearing Screening Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Neonatal Hearing Screening Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • FRANCE
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • GERMANY
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Neonatal Hearing Screening Devices by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Neonatal Hearing Screening Devices by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • INDIA
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Neonatal Hearing Screening Devices by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Neonatal Hearing Screening Devices by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Neonatal Hearing Screening Devices by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Neonatal Hearing Screening Devices by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030
  • AFRICA
    • Neonatal Hearing Screening Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Neonatal Hearing Screening Devices by Product - Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Neonatal Hearing Screening Devices by Product - Percentage Breakdown of Value Sales for Auditory Brainstem Response (ABR) Systems, Otoacoustic Emission (OAE) Systems and Combination Systems for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Neonatal Hearing Screening Devices by End-Use - Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Neonatal Hearing Screening Devices by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Specialty Clinics End-Use and Other End-Uses for the Years 2014, 2024 & 2030

IV. COMPETITION